# Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial

> **NCT01678534** · PHASE2 · COMPLETED · sponsor: **Instituto de Investigación Hospital Universitario La Paz** · enrollment: 19 (actual)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** Allogenic mesenchymal stem cells from adipose tissue
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01678534
- **Lead sponsor:** Instituto de Investigación Hospital Universitario La Paz
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2018-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01678534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01678534, "Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01678534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*